Remove Drug Development Remove Life Science Remove Pharmaceuticals Remove Telemedicine
article thumbnail

Healthcare AI investment will shift to these 5 areas in the next 2 years: survey

Henry Kotula

The majority of healthcare and life sciences executives (82%) want to see their organizations more aggressively adopt AI technology, according to a new survey from KPMG, an audit, tax and advisory services firm. However, life sciences companies seem to be struggling to select the best AI technologies, according to 73% of executives.

article thumbnail

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 107
article thumbnail

Where are HealthTech's soft landing M&A deals in today's market?

Lloyd Price

Traditional healthcare players: Hospitals, insurers, and pharmaceutical companies are increasingly acquiring healthtech startups to improve efficiency, patient engagement, and data-driven decision making. Examples: CVS Health acquiring telemedicine provider Aetna, Ascension acquiring teleICU company Aidiant.